Year Ahead

President Trump Is The Wild Card On Drug-Pricing Action In 2020

By John Wilkerson, Ariel Cohen / January 2, 2020 at 3:51 PM

The new year ushers in continued uncertainty over proposals to lower prescription drug prices, and President Donald Trump is viewed as the wildcard on whether Congress will pass major drug pricing legislation.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Year Ahead

President Trump Is The Wild Card On Drug-Pricing Action In 2020

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.